If you have been diagnosed with adult-onset, or type 2, diabetes, chances are good that you have been prescribed Canagliflozin, sold under the trade names Invokana or Sulisent. Invokana, marketed by Janssen, a division of Johnson & Johnson, is supposed to improve sugar control in patients with type 2 diabetes. The product was approved for sale in the United States in March, 2013.
According to the U.S Food and Drug Administration (FDA), though, Invokana has been linkedto a wide range of health issues, from low blood sugar and extreme dehydration to loss of consciousness and allergic reactions. Some Invokana users have reported broken bones, pancreatitis, loss of bone density and kidney disease. The FDA also acknowledges that Invokana may increase risk of urinary tract infections and elevated cholesterol levels, as well as diabetic ketoacidosis, a potentially life-threatening condition.
If you or someone you love has suffered adverse health events after using Invokana, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.
Defective Drugs & Medical Devices Topics
Happy 4th of July
Our country is not the only thing to which we owe our allegiance. It is also owed to justice and to…Read More 02 Jul 2020, Thursday
Supreme Court Issues Landmark LGBT Employment Law Ruling
Decision Applies Civil Rights Act to Employment Issues in All 50 States The United States Supreme Co…Read More 25 Jun 2020, Thursday
President Seeks to Limit Liability of Meat Companies for COVID-19
Industry Continues to Be Hotspot for COVID Infection State health officials in Idaho announced on Tu…Read More 09 Jun 2020, Tuesday